Illumina
Illumina is a developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. Illumina has developed a line of DNA sequencing technology products that address the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests.
Illumina News
Under a three-year deal, Illumina has licensed access to Tempus' multimodal data platform, which includes DNA and RNA data, clinical data, pathology slides, and radiology scans.
Illumina Lays off More Than 300 Employees
The company has reduced its head count by approximately 5 percent so far this year and has laid off approximately 1,000 employees since late 2022.
Illumina, Tempus AI Collaborate on Generating Evidence for Clinical NGS-Based Testing
The companies plan to combine Tempus' multimodal data platform and Illumina's AI-driven molecular analysis technologies.
The organizations launched the clinical trial to assess clinical utility of whole-genome sequencing in cardiovascular disease care.
People in the News at Illumina, Pacific Biosciences, Vizgen, NYGC, ACMG, AACR, Roche
Recently posted executive and academic appointments, promotions, and departures in omics and molecular diagnostics.